Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance von Zitvogel, Laurence, Galluzzi, Lorenzo, Smyth, Mark J., Kroemer, Guido

Volltext

Balancing natural killer cell activation through paired receptors von Martinet, Ludovic, Smyth, Mark J.

Volltext

Targeting natural killer cells in cancer immunotherapy von Guillerey, Camille, Huntington, Nicholas D, Smyth, Mark J

Volltext

Cancer immunoediting and immune dysregulation in multiple myeloma von Nakamura, Kyohei, Smyth, Mark J., Martinet, Ludovic

Volltext

Targeting cancer‐related inflammation in the era of immunotherapy von Nakamura, Kyohei, Smyth, Mark J

Volltext

The pre-metastatic niche: finding common ground von Sceneay, Jaclyn, Smyth, Mark J., Möller, Andreas

Volltext

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion von Schreiber, Robert D., Old, Lloyd J., Smyth, Mark J.

Volltext

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy von Dougall, William C., Kurtulus, Sema, Smyth, Mark J., Anderson, Ana C.

Volltext

Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs von ALLARD, Bertrand, POMMEY, Sandra, SMYTH, Mark J, STAGG, John

Volltext

Targeting immune checkpoints in hematological malignancies von Salik, Basit, Smyth, Mark J, Nakamura, Kyohei

Volltext

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses von Young, Arabella, Ngiow, Shin Foong, Barkauskas, Deborah S., Sult, Erin, Hay, Carl, Blake, Stephen J., Huang, Qihui, Liu, Jing, Takeda, Kazuyoshi, Teng, Michele W.L., Sachsenmeier, Kris, Smyth, Mark J.

Volltext

Resistance to PD1/PDL1 checkpoint inhibition von O’Donnell, Jake S, Long, Georgina V, Scolyer, Richard A, W. L. Teng, Michele, Smyth, Mark J

Volltext

BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies von Ambalathingal, George R, Francis, Ross S, Smyth, Mark J, Smith, Corey, Khanna, Rajiv

Volltext

Targeting cancer-derived adenosine: new therapeutic approaches von Young, Arabella, Mittal, Deepak, Stagg, John, Smyth, Mark J

Volltext

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases von Teng, Michele W L, Bowman, Edward P, McElwee, Joshua J, Smyth, Mark J, Casanova, Jean-Laurent, Cooper, Andrea M, Cua, Daniel J

Volltext

Natural innate and adaptive immunity to cancer von Vesely, Matthew D, Kershaw, Michael H, Schreiber, Robert D, Smyth, Mark J

Volltext

The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment von O'Donnell, Jake S, Hoefsmit, Esmée P, Smyth, Mark J, Blank, Christian U, Teng, Michele W L

Volltext

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells von Ma, Yuting, Adjemian, Sandy, Mattarollo, Stephen R., Yamazaki, Takahiro, Aymeric, Laetitia, Yang, Heng, Portela Catani, João Paulo, Hannani, Dalil, Duret, Helene, Steegh, Kim, Martins, Isabelle, Schlemmer, Frederic, Michaud, Mickaël, Kepp, Oliver, Sukkurwala, Abdul Qader, Menger, Laurie, Vacchelli, Erika, Droin, Nathalie, Galluzzi, Lorenzo, Krzysiek, Roman, Gordon, Siamon, Taylor, Philip R., Van Endert, Peter, Solary, Eric, Smyth, Mark J., Zitvogel, Laurence, Kroemer, Guido

Volltext

The TRAIL apoptotic pathway in cancer onset, progression and therapy von Johnstone, Ricky W, Smyth, Mark J, Frew, Ailsa J

Volltext

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment von Young, Arabella, Ngiow, Shin Foong, Gao, Yulong, Patch, Ann-Marie, Barkauskas, Deborah S, Messaoudene, Meriem, Lin, Gene, Coudert, Jerome D, Stannard, Kimberley A, Zitvogel, Laurence, Degli-Esposti, Mariapia A, Vivier, Eric, Waddell, Nicola, Linden, Joel, Huntington, Nicholas D, Souza-Fonseca-Guimaraes, Fernando, Smyth, Mark J

Volltext